—
C+
C+ The full Closelook — membership. Open the C+ overview

HealthEquity Inc（HQY）— 同業公司組

數據截至2026-09-24 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

HealthEquity Inc的Closelook綜合評分為61/100，在同業公司組內排名第5位（共9家）——組內評分最高的是Halozyme Therapeutics Inc（74/100）。

名稱綜合動能品質估值訊號距52週高點
HQY HealthEquity Inc61596945info17.7%
VEEV Veeva Systems Inc Class A60877432bull12.8%
HNGE Hinge Health, Inc.57946335ok4.8%
BTSG BrightSpring Health Services, Inc. Common Stock48532540info24%
TEM Tempus AI, Inc. Class A Common Stock38691814bull26.6%
HALO Halozyme Therapeutics Inc74969445ok1.4%
DXCM DexCom Inc66858036neutral5.2%
ARGX argenx NV ADR64747327ok10.3%
ONC BeiGene, Ltd.64796332ok6.6%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-09-24

Quick answers

HealthEquity Inc在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：Veeva Systems Inc Class A (VEEV)、Hinge Health, Inc. (HNGE)、BrightSpring Health Services, Inc. Common Stock (BTSG)、Tempus AI, Inc. Class A Common Stock (TEM)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、argenx NV ADR (ARGX)、BeiGene, Ltd. (ONC)。

HQY相對同業公司的評分如何？

HealthEquity Inc的綜合評分為61/100，組內排名第5位（共9家），截至2026-09-24；組內最高綜合評分為Halozyme Therapeutics Inc（74/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelook universe

then Health Information Services, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.